Breast cancer screening by clinical breast examination and a new instrument named iBreastExam

A pilot study for breast cancer screening by clinical breast examination (CBE) and iBreastExam (iBE) for early detection of breast cancer - NA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/022727

Enrollment

4000

Registered

2020-01-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Clinical breast examination: Clinical breast examination (CBE) is a low-cost option for improving breast awareness and early detection of breast cancer. Control Intervention1: iBreastEx

Eligibility

Inclusion criteria

Inclusion criteria: Consenting women

Exclusion criteria

Exclusion criteria: Women who have undergone breast surgery

Design outcomes

Primary

Measure	Time frame
1. The outcome will be women detected with breast cancer correctly by clinical breast examination and iBreastExam 2. Test performance of clinical breast exam and iBreastExam in detecting breast cancerTimepoint: single	—

Secondary

Measure	Time frame
To study the test performance of CBE and iBreastExam in detecting lumps with histopathology as the reference standard Timepoint: cross-sectional	—

Countries

India

Contacts

Public ContactDr Smita Joshi

Prayas

smitanjoshi18@gmail.com9881132506

Outcome results